PetMed Express, Inc.
PETS
$2.46
$0.031.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.75% | -23.57% | -22.70% | -21.95% | -20.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.75% | -23.57% | -22.70% | -21.95% | -20.45% |
| Cost of Revenue | -12.91% | -18.64% | -22.03% | -21.90% | -24.46% |
| Gross Profit | -41.38% | -33.87% | -24.34% | -22.02% | -9.80% |
| SG&A Expenses | 18.47% | 6.39% | 47.87% | 20.38% | -22.94% |
| Depreciation & Amortization | 51.26% | 37.39% | 32.66% | 9.45% | -10.40% |
| Other Operating Expenses | -- | -- | -- | -8.27% | -- |
| Total Operating Expenses | -2.07% | -9.90% | -6.02% | -3.91% | -23.67% |
| Operating Income | -4,240.25% | -932.21% | -249.48% | -502.07% | 92.16% |
| Income Before Tax | -4,256.20% | -1,020.11% | -824.60% | -71.90% | 90.85% |
| Income Tax Expenses | -97.63% | 100.64% | -99.06% | 268.62% | 175.24% |
| Earnings from Continuing Operations | -1,392.64% | -466.29% | -1,009.75% | -132.14% | 65.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,392.64% | -466.29% | -1,009.75% | -132.14% | 65.12% |
| EBIT | -4,240.25% | -932.21% | -249.48% | -502.07% | 92.16% |
| EBITDA | -699.33% | -293.76% | -171.87% | -771.99% | 203.14% |
| EPS Basic | -1,364.43% | -461.29% | -999.18% | -129.91% | 65.42% |
| Normalized Basic EPS | -31,240.00% | -683.16% | -238.08% | -613.31% | 98.76% |
| EPS Diluted | -1,364.43% | -472.73% | -1,016.67% | -126.13% | 65.70% |
| Normalized Diluted EPS | -31,240.00% | -694.28% | -240.94% | -613.31% | 98.76% |
| Average Basic Shares Outstanding | 1.81% | 1.41% | 1.18% | 0.95% | 1.03% |
| Average Diluted Shares Outstanding | 1.81% | -0.24% | -0.89% | 0.95% | 1.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.93% | -1.08% | -1.00% | 0.88% | 0.81% |